⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 6, 2015Radiation OncologyOpen Access

Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy

Ciro Franzese Antonella Fogliata Elena Clerici Davide Franceschini E. Villa Giuseppe Roberto D’Agostino Piera Navarria Pietro Mancosu Stefano Tomatis Luca Cozzi Marta Scorsetti

View Full Paper

Ask AI

Bookmark

Share

Abstract

RapidArc technology and SIB with 1.65 and 2.12Gy/fraction for 33 fractions showed a good toxicity profile and encouraging trend for OS and DFS for patients with stage III-IV HNC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Franzese et al. (2015) studied this question.

synapsesocial.com/papers/69dc65ce4264bdb3843592df https://doi.org/10.1186/s13014-015-0535-0

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialCohort Study · 2011 · 1,709 citations
2Intensity-Modulated Radiation Therapy for Head and Neck CarcinomaOriginal Research · 2007 · 122 citations
3Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapyRetrospective Study · 2009 · 100 citations
4Within-patient four-dimensional computed tomography analysis reveals location-dependent motion of thoracic lymph nodes during respirationRadiation Oncology · Mon,
5Fine-mapping of microbeam radiation therapy-induced DNA damage in 2D cell and 3D epidermis modelsRadiation Oncology · Mon,

More from Radiation Oncology

Prognostic value of body composition combined with Epstein-Barr virus DNA and platelet-to-lymphocyte ratio in locally advanced nasopharyngeal carcinomaSat,
Microbeam radiotherapy – clinical and dosimetric investigation of a first clinical applicationFri,
Risk-stratified management of stage IB nasopharyngeal carcinoma under the 9th edition TNM staging system: a prognostic nomogram integrating MRI nodal features and Epstein–Barr virus DNAFri,
Electronic patient-reported outcome assessment at inpatient admission: a descriptive analysis of real-world data for 1423 radiotherapy patientsFri,
Feasibility study of dose calculation based on contrast-enhanced computed tomography for stereotactic body radiation therapy of lung metastases treated with MR-LinacWed,